The following represents disclosure information provided by the author of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted ...
In 1998, McLaughlin et al 1 demonstrated that nearly half of patients with relapsed and refractory indolent B-cell lymphoma responded to single-agent anti-CD20 monoclonal antibody treatment with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results